|
Volumn 8, Issue 1, 2001, Pages 55-62
|
Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy
|
Author keywords
Cancer immunotherapy; Fusogenic activity; Gene therapy; IL 12; VSVG
|
Indexed keywords
GREEN FLUORESCENT PROTEIN;
INTERLEUKIN 12;
POVIDONE;
VIRUS GLYCOPROTEIN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CANCER IMMUNOTHERAPY;
CANCER INHIBITION;
COLON CARCINOMA;
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
GENE EXPRESSION;
GENE TARGETING;
GENE THERAPY;
KIDNEY CARCINOMA;
MOUSE;
NONHUMAN;
PLASMID;
PRIORITY JOURNAL;
SYNCYTIUM;
VESICULAR STOMATITIS VIRUS;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLOTTING, WESTERN;
CARCINOMA, RENAL CELL;
COLONIC NEOPLASMS;
DRUG DELIVERY SYSTEMS;
DRUG SYNERGISM;
FEMALE;
GENE THERAPY;
GIANT CELLS;
GRAFT REJECTION;
GREEN FLUORESCENT PROTEINS;
HYDROGEN-ION CONCENTRATION;
INTERLEUKIN-12;
KIDNEY NEOPLASMS;
LUMINESCENT PROTEINS;
MEMBRANE GLYCOPROTEINS;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
MICROSCOPY, FLUORESCENCE;
PLASMIDS;
POVIDONE;
VIRAL ENVELOPE PROTEINS;
ANIMALIA;
BACTERIA (MICROORGANISMS);
MURINAE;
VESICULAR STOMATITIS VIRUS;
|
EID: 0035125507
PISSN: 09291903
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.cgt.7700270 Document Type: Article |
Times cited : (11)
|
References (26)
|